Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL DNA AND GENE CHIP INDUSTRY
2.1 Summary about DNA and Gene Chip Industry
2.2 DNA and Gene Chip Market Trends
2.2.1 DNA and Gene Chip Production & Consumption Trends
2.2.2 DNA and Gene Chip Demand Structure Trends
2.3 DNA and Gene Chip Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Oligonucleotide DNA microarrays (oDNA)
4.2.2 Complementary DNA microarrays (cDNA)
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Gene expression
4.3.2 Cancer diagnostics & treatments
4.3.3 Drug discovery
4.3.4 Genetics
4.3.5 SNP analysis
4.3.6 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Oligonucleotide DNA microarrays (oDNA)
5.2.2 Complementary DNA microarrays (cDNA)
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Gene expression
5.3.2 Cancer diagnostics & treatments
5.3.3 Drug discovery
5.3.4 Genetics
5.3.5 SNP analysis
5.3.6 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Oligonucleotide DNA microarrays (oDNA)
6.2.2 Complementary DNA microarrays (cDNA)
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Gene expression
6.3.2 Cancer diagnostics & treatments
6.3.3 Drug discovery
6.3.4 Genetics
6.3.5 SNP analysis
6.3.6 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Oligonucleotide DNA microarrays (oDNA)
7.2.2 Complementary DNA microarrays (cDNA)
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Gene expression
7.3.2 Cancer diagnostics & treatments
7.3.3 Drug discovery
7.3.4 Genetics
7.3.5 SNP analysis
7.3.6 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Oligonucleotide DNA microarrays (oDNA)
8.2.2 Complementary DNA microarrays (cDNA)
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Gene expression
8.3.2 Cancer diagnostics & treatments
8.3.3 Drug discovery
8.3.4 Genetics
8.3.5 SNP analysis
8.3.6 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Oligonucleotide DNA microarrays (oDNA)
9.2.2 Complementary DNA microarrays (cDNA)
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Gene expression
9.3.2 Cancer diagnostics & treatments
9.3.3 Drug discovery
9.3.4 Genetics
9.3.5 SNP analysis
9.3.6 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 AFFYMETRIX INC
10.1.2 AGILENT TECHNOLOGIES INC
10.1.3 BIOMIEUX SA
10.1.4 BIOMETRIX TECHNOLOGY INC
10.1.5 BIONEER CORP
10.1.6 CAPITALBIO CORP
10.1.7 EUROFINS MWG OPERON
10.1.8 GREINER BIO-ONE
10.1.9 ILLUMINA INC
10.1.10 LC SCIENCES
10.1.11 LIFEGEN TECHNOLOGIES
10.1.12 LIFE TECHNOLOGIES CORP
10.1.13 MACROGEN INC
10.1.14 MICROARRAYS INC
10.1.15 NGK INSULATORS LTD
10.1.16 ROCHE NIMBLEGEN INC
10.1.17 SIGMA-ALDRICH
10.2 DNA and Gene Chip Sales Date of Major Players (2017-2020e)
10.2.1 AFFYMETRIX INC
10.2.2 AGILENT TECHNOLOGIES INC
10.2.3 BIOMIEUX SA
10.2.4 BIOMETRIX TECHNOLOGY INC
10.2.5 BIONEER CORP
10.2.6 CAPITALBIO CORP
10.2.7 EUROFINS MWG OPERON
10.2.8 GREINER BIO-ONE
10.2.9 ILLUMINA INC
10.2.10 LC SCIENCES
10.2.11 LIFEGEN TECHNOLOGIES
10.2.12 LIFE TECHNOLOGIES CORP
10.2.13 MACROGEN INC
10.2.14 MICROARRAYS INC
10.2.15 NGK INSULATORS LTD
10.2.16 ROCHE NIMBLEGEN INC
10.2.17 SIGMA-ALDRICH
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
